Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome

Zilli, Thomas; Jorcano, S; Escudé, L; Linero, D; Rouzaud, M; Dubouloz, A; Miralbell, Raymond

doi:10.1016/j.clon.2014.02.014

Scientific article

English

Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome

ContributorsZilli, Thomas; Jorcano, S; Escudé, L; Linero, D; Rouzaud, M; Dubouloz, A; Miralbell, Raymond

Published inClinical oncology, vol. 26, no. 6, p. 316-322

Publication date2014

Abstract

To evaluate the tolerance and preliminary outcome of prostate cancer patients at high risk of lymph node involvement treated with normofractionated whole pelvic radiotherapy (WPRT) followed by a hypofractionated boost to the prostate with an intensity-modulated radiotherapy (IMRT) technique.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de radiologie et informatique médicale

Research groups

Groupe Miralbell Raymond (radio-oncologie) (685)

Citation (ISO format)

ZILLI, Thomas et al. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome. In: Clinical oncology, 2014, vol. 26, n° 6, p. 316–322. doi: 10.1016/j.clon.2014.02.014

Article (Published version)

Identifiers

PID : unige:44334
DOI : 10.1016/j.clon.2014.02.014
PMID : 24667210

Journal ISSN0936-6555

581views

1downloads

Creation23/12/2014 10:37:00

First validation23/12/2014 10:37:00

Update time14/03/2023 22:33:40

Status update14/03/2023 22:33:39

Last indexation30/10/2024 21:50:37

Archive ouverte UNIGE

Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome

To evaluate the tolerance and preliminary outcome of prostate cancer patients at high risk of lymph node involvement treated with normofractionated whole pelvic radiotherapy (WPRT) followed by a hypofractionated boost to the prostate with an intensity-modulated radiotherapy (IMRT) technique.

Technical informations